EntrezGene:51282

Symbol:

SCAND1

Description:

SCAN domain containing 1

Synonyms:

RAZ1, SDP1

Species:

Human (Homo sapiens)

Xrefs:

ExpandEntrezGene:51282

Associated motifs:

NA

Transcripton Factor?:

No

TSS regions

Show entries

Search:

TSS peak ID	Short_description
Hg19::chr20:34542174..34542185,-	p11@SCAND1
Hg19::chr20:34542200..34542215,-	p3@SCAND1
Hg19::chr20:34542216..34542278,-	p2@SCAND1
Hg19::chr20:34542352..34542363,-	p6@SCAND1
Hg19::chr20:34542383..34542451,-	p1@SCAND1
Hg19::chr20:34542452..34542464,-	p4@SCAND1
Hg19::chr20:34542557..34542575,-	p5@SCAND1
Hg19::chr20:34542920..34542943,-	p7@SCAND1

Showing 1 to 8 of 8 entries

Previous1Next

View on UCSC genome browser

Mouse over to see Genome browser image, Click image to go to Genome browser

TSS expression

Search:

Sample	p1@SCAND1	p2@SCAND1	p3@SCAND1	p4@SCAND1	p5@SCAND1
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7	346.93	228.90	10.73	3.58	0.00
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1	212.83	75.57	3.08	12.34	7.71
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6	165.38	141.65	11.16	5.58	2.79
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7	154.71	46.97	2.76	5.53	0.00
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3	141.44	35.12	2.85	5.70	0.95
Melanocyte - light, donor3.CNhs12033.11423-118G1	138.57	47.90	3.42	3.42	0.00
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3	136.44	106.88	9.10	9.10	0.00
Melanocyte - light, donor2.CNhs11383.11351-117H1	128.94	75.02	8.21	18.75	0.00
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1	128.49	47.90	3.80	3.80	0.00
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3	127.31	32.69	0.00	2.58	1.72
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7	127.25	26.06	3.07	3.07	1.53
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8	122.01	29.45	2.80	4.21	0.00
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8	119.28	32.22	2.26	2.83	1.70
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2	119.09	32.41	2.43	0.81	0.00
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9	112.46	190.36	17.58	2.43	3.94
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9	112.02	23.62	2.30	5.64	1.46
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2	111.46	26.16	0.00	1.14	1.14
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3	111.46	65.15	2.35	6.28	3.14
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8	108.92	119.05	2.53	5.07	2.53
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3	107.61	81.74	4.14	5.17	1.03
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2	106.36	71.86	2.16	5.03	1.44
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9	105.56	15.50	2.21	2.95	0.74
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3	104.24	26.75	1.10	2.38	1.28
Pericytes, donor1.CNhs11317.11491-119E6	98.49	54.43	2.74	4.31	0.59
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4	98.16	19.72	2.10	2.52	0.42
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5	97.20	71.84	10.57	6.34	3.17
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5	96.53	69.90	4.99	3.33	3.33
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2	95.43	32.85	3.13	1.56	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6	94.93	49.72	2.26	3.39	1.13
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1	93.62	18.68	0.80	3.18	1.39
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8	90.71	62.25	2.54	4.79	2.25
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8	90.64	39.00	2.97	1.11	1.11
Pericytes, donor2.CNhs12079.11571-120E5	90.25	56.62	3.09	5.15	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4	89.26	11.00	1.51	3.44	0.83
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1	88.08	58.72	1.76	4.99	0.29
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1	87.94	25.17	1.87	2.55	2.04
CD34+ Progenitors, donor1.CNhs13227.11545-120B6	87.23	46.26	3.97	1.32	0.00
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1	86.43	50.74	1.75	1.75	0.70
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5	85.07	37.74	1.84	3.26	1.84
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7	84.69	107.95	6.51	4.03	3.10
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9	84.45	30.20	1.28	6.14	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5	84.23	12.38	1.13	3.54	1.29
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6	82.91	21.56	1.12	5.21	0.99
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9	82.00	33.15	3.49	5.23	2.62
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7	81.46	50.59	2.55	2.55	0.64
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8	81.43	11.22	2.49	4.57	0.42
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2	80.85	39.69	2.94	4.41	0.00
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4	80.84	133.15	9.51	0.00	4.76
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9	80.31	52.63	2.71	2.17	0.00
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8	79.50	16.32	0.69	2.78	0.00
Cardiac Myocyte, donor1.CNhs12341.11525-119I4	78.02	31.69	2.44	0.00	2.44
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4	77.99	30.29	2.38	1.67	1.91
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4	77.45	89.14	2.92	1.46	0.00
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1	77.18	68.14	3.73	2.66	0.00
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8	76.22	39.35	1.24	4.03	0.31
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4	76.08	29.17	4.58	2.86	0.57
brain, fetal, pool1.CNhs11797.10085-102B4	75.85	31.94	0.00	2.00	2.00
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9	74.83	26.69	1.38	2.75	1.93
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5	74.29	64.89	4.07	2.51	0.31
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2	74.21	31.17	2.97	0.00	4.45
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5	74.07	27.18	1.07	4.26	1.60
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4	73.72	36.65	0.84	2.53	2.95
Neurons, donor1.CNhs12338.11494-119E9	73.46	37.12	3.09	6.19	0.77
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1	72.85	63.25	0.80	4.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6	72.69	33.80	1.39	2.78	0.46
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5	72.66	36.08	3.90	3.90	0.49
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5	72.45	38.79	0.00	3.99	0.00
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1	72.00	24.16	1.22	1.22	0.24
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4	71.52	59.78	2.13	2.13	0.00
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5	71.52	63.02	3.00	2.00	1.50
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5	71.24	89.80	5.52	4.52	1.51
Adipocyte - omental, donor3.CNhs12068.11475-119C8	71.07	37.99	3.58	2.23	1.34
Urothelial Cells, donor2.CNhs12091.11600-120H7	70.76	38.75	0.00	1.68	1.68
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6	70.54	29.77	3.15	4.16	0.79
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8	69.96	54.39	4.04	2.02	0.81
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8	69.58	29.52	2.11	6.33	6.33
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5	69.51	25.53	1.42	7.09	1.42
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7	68.18	41.81	1.93	2.57	0.64
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8	68.12	52.16	7.13	2.28	1.43
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3	67.99	98.89	2.21	1.32	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9	66.79	29.93	2.92	2.92	0.00
leiomyoma cell line:15242A.CNhs11723.10570-108B3	66.55	42.35	0.86	1.73	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9	66.29	86.32	10.31	0.88	1.18
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4	66.25	28.51	3.56	2.73	2.10
liver, fetal, pool1.CNhs11798.10086-102B5	66.25	47.70	0.00	2.65	0.00
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4	66.19	37.71	2.44	2.44	1.36
Melanocyte - light, donor1.CNhs11303.11274-116H5	66.08	46.22	1.91	6.49	3.44
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5	65.97	46.26	2.39	2.05	0.57
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3	65.80	30.05	1.20	1.65	2.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5	65.68	27.97	3.65	4.86	2.43
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5	64.86	25.38	1.61	3.63	0.81
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8	64.48	26.91	1.12	0.00	0.00
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6	63.78	30.41	1.35	2.83	0.62
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6	63.67	36.10	4.51	4.51	1.00
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5	63.50	61.99	5.14	2.12	3.02
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6	63.49	105.82	2.35	2.35	0.94
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4	63.24	34.77	2.02	2.77	3.02
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5	63.24	41.23	1.53	1.71	0.63
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2	62.78	19.09	2.51	3.01	2.01
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4	62.68	43.62	2.35	2.09	2.35
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4	62.67	111.60	0.86	3.43	1.72
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1	62.51	42.25	1.16	1.74	0.00
leiomyoma cell line:10964C.CNhs11722.10569-108B2	62.44	61.90	4.89	3.26	1.09
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8	61.74	37.05	0.00	1.65	0.00
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3	61.48	38.96	1.62	3.65	0.41
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7	61.09	27.99	2.11	3.31	1.20
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4	60.93	44.40	4.69	2.22	1.48
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7	60.71	26.89	1.07	2.99	0.53
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4	60.51	34.70	3.56	2.67	0.89
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5	60.39	90.20	5.49	2.35	0.78
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1	60.33	68.37	2.68	4.02	2.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5	60.20	36.31	0.96	7.64	0.00
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6	60.02	20.29	1.69	4.23	0.85
Cardiac Myocyte, donor2.CNhs12350.11605-120I3	59.69	48.96	2.01	4.02	0.00
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8	59.34	43.98	1.81	1.20	0.60
Keratocytes, donor2.CNhs12095.11607-120I5	59.28	40.56	4.16	4.16	1.04
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9	59.10	18.96	2.03	2.58	1.66
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7	59.10	11.90	0.64	2.98	0.43
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1	58.77	92.98	4.17	1.97	0.44
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6	58.75	48.55	1.85	2.41	0.56
Mesothelial Cells, donor1.CNhs10850.11247-116E5	58.48	32.86	1.81	2.11	1.21
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4	58.48	39.94	1.43	5.71	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3	58.27	52.15	3.38	0.52	0.78
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1	58.09	27.54	1.31	3.28	0.66
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5	57.99	61.97	2.98	1.33	1.66
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5	57.66	9.80	0.45	2.25	0.34
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8	57.62	27.89	0.92	1.84	1.84
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6	57.61	25.46	1.29	2.31	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3	57.49	68.63	3.57	0.56	0.67
Neurons, donor3.CNhs13815.11655-122E8	57.41	31.90	3.83	7.66	0.64
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7	57.40	34.44	2.30	1.97	0.66
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4	57.00	67.12	8.27	0.00	3.68
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9	56.98	37.69	0.89	1.77	1.11
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7	56.87	32.14	3.46	1.48	1.24
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1	56.81	11.90	0.67	1.57	1.80
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2	56.79	42.46	2.76	2.21	1.65
Mast cell, donor3.CNhs12593.11566-120D9	56.78	24.64	4.04	3.03	1.15
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6	56.47	37.45	2.30	1.73	0.00
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3	56.39	30.87	0.82	2.88	1.65
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2	56.35	35.52	1.53	1.22	1.84
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7	56.12	54.81	2.63	1.32	0.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8	55.98	51.75	2.05	1.28	0.51
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8	55.87	30.19	3.45	1.05	1.50
occipital lobe, adult, donor1.CNhs11787.10076-102A4	55.79	30.36	1.85	1.64	1.03
Osteoblast, donor3.CNhs12036.11426-118G4	55.68	33.74	0.74	3.69	0.74
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6	55.61	90.16	11.52	1.11	0.66
Basophils, donor1.CNhs12546.12241-129G9	55.46	44.06	9.05	0.39	1.97
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9	55.41	31.97	1.70	1.28	1.70
Hepatocyte, donor2.CNhs12349.11603-120I1	55.04	54.06	1.97	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9	54.78	19.40	0.23	3.20	1.37
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7	54.72	30.84	3.80	1.90	1.27
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2	54.58	32.51	2.91	2.67	2.91
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6	54.57	33.53	1.78	3.21	0.71
Urothelial Cells, donor3.CNhs12122.11681-122H7	54.54	27.94	2.22	0.44	1.33
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3	54.43	38.18	3.29	1.46	2.19
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1	54.40	22.00	0.40	4.40	0.80
Synoviocyte, donor3.CNhs12050.11440-118H9	54.00	26.34	0.99	0.66	0.99
Hepatocyte, donor3.CNhs12626.11684-122I1	53.76	43.72	2.36	1.77	1.18
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5	53.29	14.33	0.22	2.46	1.12
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2	53.19	71.47	4.99	1.66	0.00
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4	52.97	45.31	4.88	4.88	0.00
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7	52.92	35.81	2.59	0.99	5.57
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7	52.45	21.44	1.32	1.98	2.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6	52.44	15.78	0.00	1.86	0.46
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8	52.40	49.60	2.34	1.17	0.70
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6	51.67	22.02	1.24	2.66	0.89
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2	51.31	37.68	0.80	1.60	0.80
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2	51.24	41.08	4.44	2.86	1.43
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1	51.11	19.06	0.87	1.88	0.29
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3	50.91	10.34	0.78	1.29	0.52
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1	50.64	41.19	4.16	1.51	1.13
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2	50.53	22.49	1.08	2.16	0.62
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4	50.51	42.35	1.56	1.91	2.43
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3	50.43	25.39	4.58	1.41	1.06
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2	50.31	32.66	1.58	5.00	0.26
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7	50.13	28.51	1.97	0.98	0.25
Adipocyte - omental, donor2.CNhs12067.11474-119C7	50.04	38.03	3.00	5.00	2.00
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6	50.00	11.77	2.21	1.84	1.47
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3	49.86	26.43	2.40	0.60	1.20
Myoblast, donor2.CNhs11965.11322-117D8	49.73	22.81	0.41	2.88	1.03
tenocyte, donor2.CNhs12640.11765-123I1	49.45	40.67	0.92	1.85	1.85
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6	49.43	20.26	0.61	1.69	0.61
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6	49.43	14.65	1.37	1.60	0.69
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9	49.39	22.97	0.00	1.15	0.00
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7	49.39	21.15	0.58	1.74	0.81
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1	49.32	37.84	7.02	2.13	1.28
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8	49.10	30.09	2.38	3.17	0.79
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9	49.03	22.69	1.21	1.70	0.24
CD14+ Monocytes, donor3.CNhs11997.11381-118B4	48.83	32.33	4.99	1.74	1.52
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3	48.71	25.52	1.16	0.00	0.00
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4	48.64	19.15	1.31	1.90	0.36
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9	48.56	26.17	1.89	1.89	2.18
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1	48.20	113.00	3.95	0.79	0.79
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5	47.96	30.52	2.49	1.87	2.49
Meningeal Cells, donor2.CNhs12080.11573-120E7	47.96	23.54	0.44	3.49	0.44
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9	47.96	27.15	0.39	2.46	0.39
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9	47.94	46.35	7.96	1.99	1.79
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8	47.63	37.53	1.44	1.44	1.44
tenocyte, donor3.CNhs12641.11768-123I4	47.59	30.72	1.30	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4	47.52	96.57	18.39	1.53	1.15
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5	47.36	42.26	4.01	1.46	0.36
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6	47.28	40.72	0.62	2.23	0.37
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1	47.28	15.02	0.28	2.48	0.69
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9	47.28	61.49	1.35	1.56	0.41
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7	47.10	36.49	3.32	0.66	1.99
mesothelioma cell line:ONE58.CNhs13075.10858-111G3	47.10	43.15	1.52	0.91	1.22
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2	46.95	32.18	1.32	2.90	0.79
Natural Killer Cells, donor2.CNhs11957.11311-117C6	46.79	49.38	9.70	0.65	3.67
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9	46.77	63.26	5.75	1.15	1.15
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9	46.70	54.44	3.04	1.11	0.28
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6	46.67	33.22	0.55	2.20	0.82
Mast cell, donor2.CNhs12594.11565-120D8	46.44	18.24	3.11	3.94	2.07
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9	46.42	28.21	1.80	2.05	0.26
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5	46.32	17.54	0.76	1.91	0.76
Synoviocyte, donor2.CNhs11992.11368-117I9	46.23	25.33	1.90	0.84	0.63
Mast cell, donor4.CNhs12592.11567-120E1	46.20	15.91	3.03	1.89	1.14
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6	46.07	72.70	3.47	2.32	0.69
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9	45.91	25.58	2.62	0.66	1.97
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1	45.73	87.11	7.62	1.09	4.36
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8	45.71	20.87	1.02	1.36	0.91
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9	45.71	18.93	1.62	1.89	0.54
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2	45.68	52.69	4.47	1.81	0.85
mesothelioma cell line:No36.CNhs13074.10857-111G2	45.60	54.92	1.38	3.11	0.69
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2	45.45	44.33	1.57	2.01	0.67
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5	45.43	22.12	1.49	2.69	0.75
Natural Killer Cells, donor3.CNhs12001.11387-118C1	45.43	43.76	9.75	0.51	1.93
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1	45.40	23.45	0.37	0.74	0.37
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7	45.34	32.53	3.59	1.28	1.54
Preadipocyte - breast, donor1.CNhs11052.11467-119B9	45.16	35.73	1.98	2.48	0.50
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5	45.12	20.45	0.32	2.27	0.97
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9	45.08	41.27	2.57	1.68	0.89
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2	44.90	18.64	0.57	2.09	0.19
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9	44.81	32.25	1.36	1.02	0.00
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7	44.71	31.40	2.08	1.25	0.83
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9	44.64	24.97	0.94	2.81	1.25
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6	44.60	22.68	1.39	1.77	0.76
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9	44.48	47.19	3.93	1.97	0.74
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7	44.33	162.64	22.16	0.33	0.65
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8	44.08	35.52	1.28	2.14	0.00
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9	44.03	46.20	3.61	2.89	0.00
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6	43.73	19.85	0.58	0.86	1.73
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3	43.40	12.63	0.30	2.68	0.30
CD14+ Monocytes, donor2.CNhs11954.11305-117B9	43.32	23.46	4.21	0.60	1.40
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4	43.29	13.47	1.13	3.60	0.82
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2	43.26	30.74	2.28	1.14	0.00
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8	43.02	6.15	0.00	2.79	1.12
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6	43.00	34.40	3.49	0.70	4.88
heart, adult, diseased, donor1.CNhs11758.10051-101G6	42.92	36.48	1.29	1.72	0.86
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6	42.87	31.00	2.03	2.17	1.01
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6	42.83	20.62	1.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5	42.82	34.50	0.92	2.16	0.31
colon, adult, donor1.CNhs11794.10082-102B1	42.80	18.91	0.00	1.00	1.00
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3	42.78	26.39	0.00	0.91	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5	42.78	12.31	0.20	1.41	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9	42.77	29.63	1.68	0.67	0.34
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9	42.76	24.00	1.31	4.36	0.00
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9	42.72	29.41	0.79	1.99	0.60
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8	42.71	102.29	7.87	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8	42.46	29.90	2.26	0.75	2.01
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5	42.43	19.64	0.52	0.52	0.52
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6	42.40	17.19	0.39	1.95	0.98
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6	42.36	47.47	1.46	2.92	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8	42.24	30.56	1.37	1.72	0.00
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4	42.21	25.85	0.88	2.64	0.53
Urothelial Cells, donor1.CNhs11334.11520-119H8	42.19	24.54	2.58	1.29	0.00
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2	42.17	14.06	0.65	1.31	0.65
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4	42.15	38.69	1.57	0.94	0.79
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2	42.13	63.29	5.02	0.90	3.05
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9	42.07	10.52	0.63	2.20	0.78
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1	42.06	32.16	0.71	1.18	0.47
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7	41.95	30.18	0.51	2.05	0.00
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9	41.93	27.55	2.75	3.98	0.31
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9	41.91	23.50	0.00	1.91	1.48
Reticulocytes, biol_rep2.CNhs13553.11932-125I6	41.83	24.57	1.31	0.52	1.05
Preadipocyte - breast, donor2.CNhs11971.11328-117E5	41.82	32.00	2.53	1.40	0.56
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4	41.79	29.37	2.26	1.51	2.26
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1	41.76	73.07	1.74	1.74	0.00
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9	41.71	10.96	0.70	2.11	0.28
left ventricle, adult, donor1.CNhs11789.10078-102A6	41.71	21.19	0.66	0.00	1.99
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3	41.65	11.00	0.51	1.19	0.68
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7	41.60	49.92	1.04	1.04	0.00
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7	41.53	32.48	4.11	0.00	3.70
CD34+ Progenitors, donor2.CNhs12205.11625-122B5	41.48	49.89	8.41	2.24	1.68
left atrium, adult, donor1.CNhs11790.10079-102A7	41.45	17.15	2.14	0.00	1.43
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8	41.40	39.97	2.85	1.43	0.89
Meningeal Cells, donor1.CNhs11320.11493-119E8	41.38	14.13	0.34	1.91	0.45
migratory langerhans cells, donor3.CNhs13547.11903-125F4	41.22	22.24	0.65	1.31	0.16
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7	41.17	20.43	1.97	1.97	0.00
Neurons, donor2.CNhs12726.11574-120E8	41.04	28.65	1.34	3.35	0.17
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3	41.01	36.91	0.85	0.71	0.99
Preadipocyte - omental, donor1.CNhs11065.11468-119C1	41.00	29.60	2.18	2.43	0.38
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2	40.99	19.93	3.21	1.29	0.96
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9	40.99	27.85	1.41	2.12	0.28
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5	40.95	16.35	1.13	1.78	0.65
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4	40.95	11.88	0.16	2.73	0.16
Adipocyte - breast, donor2.CNhs11969.11327-117E4	40.89	36.61	2.14	1.50	0.64
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9	40.87	58.93	3.80	0.00	0.95
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9	40.84	47.74	3.21	1.93	0.40
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1	40.81	5.27	0.63	2.05	0.27
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6	40.67	30.79	2.47	1.57	0.90
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3	40.63	29.02	2.03	1.16	2.03
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4	40.38	31.34	1.21	1.21	2.41
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8	40.38	13.79	0.74	2.46	1.23
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9	40.35	49.56	4.87	0.27	0.00
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8	40.30	22.79	1.05	1.05	0.63
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8	40.26	30.97	5.57	0.62	1.55
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1	40.05	13.39	0.70	1.29	0.70
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6	40.02	50.76	1.63	1.63	0.33
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8	39.89	36.10	2.39	0.20	1.60
breast, adult, donor1.CNhs11792.10080-102A8	39.87	13.05	1.45	0.72	0.00
CD8+ T Cells, donor2.CNhs11956.11307-117C2	39.85	59.10	17.38	0.80	2.67
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6	39.83	50.13	2.17	1.90	0.81
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4	39.72	31.77	2.27	0.57	2.27
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8	39.72	34.08	2.56	0.51	0.51
thymus, adult, pool1.CNhs10633.10027-101D9	39.66	26.16	0.65	0.97	0.13
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4	39.52	73.76	3.53	0.35	0.71
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1	39.47	24.61	1.86	1.86	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3	39.47	19.99	1.84	0.61	1.33
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2	39.41	15.64	0.65	2.28	0.98
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4	39.25	47.83	2.71	1.35	0.45
Mesothelial Cells, donor2.CNhs12197.12156-128G5	39.22	34.86	3.49	5.23	0.00
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3	39.14	68.49	3.56	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5	39.13	22.05	1.40	1.86	0.47
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4	39.09	35.49	1.14	1.76	0.97
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8	39.02	30.51	1.42	2.13	0.00
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7	38.97	16.70	1.59	3.18	0.80
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3	38.95	23.69	1.62	1.62	0.97
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2	38.92	34.26	1.51	1.23	0.69
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7	38.83	43.36	7.12	1.29	1.51
temporal lobe, adult, pool1.CNhs10637.10031-101E4	38.82	29.37	1.36	1.63	0.41
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8	38.72	25.41	0.00	1.21	0.00
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7	38.69	19.15	0.93	1.73	0.66
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6	38.67	27.70	0.72	1.44	0.36
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8	38.56	22.87	0.27	1.06	0.27
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2	38.46	26.14	1.37	1.23	0.27
CD4+ T Cells, donor3.CNhs11998.11382-118B5	38.45	59.83	12.95	1.03	3.08
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2	38.45	42.30	0.84	0.33	0.33
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1	38.43	29.80	1.94	1.08	0.65
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7	38.39	22.77	2.29	1.21	0.40
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3	38.36	33.25	2.56	1.28	3.20
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5	38.34	19.97	1.40	2.40	1.00
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7	38.32	22.99	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7	38.26	15.58	0.76	1.36	0.15
leiomyoma cell line:15425.CNhs11724.10571-108B4	38.21	33.64	0.65	1.96	0.00
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6	38.16	21.47	1.00	2.01	0.13
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4	38.11	140.94	9.92	1.04	0.78
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6	37.95	24.12	2.48	0.71	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8	37.90	20.01	0.43	2.13	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6	37.78	26.99	0.90	1.35	0.45
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9	37.53	32.01	0.63	0.95	0.79
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5	37.49	53.11	1.64	0.16	0.00
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4	37.46	14.86	0.49	1.23	0.98
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1	37.38	22.12	1.53	1.02	0.76
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5	37.37	12.96	0.51	2.69	0.51
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9	37.35	17.41	0.00	1.68	0.00
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1	37.33	17.40	1.27	2.53	0.32
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7	37.31	9.47	0.28	1.67	1.95
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3	37.27	27.83	1.49	0.00	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8	37.19	69.01	3.23	1.97	1.18
chorionic membrane cells, donor2.CNhs12506.12239-129G7	37.10	24.46	1.28	1.56	0.37
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5	36.98	27.61	0.78	0.78	0.26
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8	36.92	17.96	0.40	0.60	0.40
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4	36.92	14.18	1.09	2.00	0.73
Preadipocyte - omental, donor2.CNhs11902.11329-117E6	36.84	33.77	0.00	2.56	1.02
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7	36.83	22.57	0.00	0.00	2.38
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9	36.78	52.48	1.68	1.46	1.12
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2	36.72	32.54	4.65	2.32	0.00
lymph node, adult, donor1.CNhs11788.10077-102A5	36.72	21.83	0.50	0.50	0.50
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8	36.68	19.43	0.93	1.87	0.47
heart, adult, pool1.CNhs10621.10016-101C7	36.60	14.51	0.67	0.67	1.12
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9	36.60	14.04	0.47	1.74	0.16
CD4+ T Cells, donor2.CNhs11955.11306-117C1	36.55	66.03	14.54	0.00	0.79
Myoblast, donor3.CNhs11908.11398-118D3	36.53	18.98	0.54	1.97	0.54
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8	36.42	26.25	4.49	0.00	1.42
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7	36.42	104.81	16.15	0.69	1.72
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1	36.42	19.85	0.90	1.19	0.60
Basophils, donor3.CNhs12575.12243-129H2	36.38	37.47	7.74	0.31	1.70
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2	36.35	28.34	2.00	2.00	0.00
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7	36.29	19.36	0.81	2.20	0.12
trachea, fetal, donor1.CNhs11766.10058-101H4	36.26	20.62	2.33	1.33	0.67
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3	36.06	22.75	1.66	0.00	0.00
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5	36.04	42.92	0.98	1.31	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9	36.02	75.99	4.45	1.07	0.82
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9	35.98	31.81	2.61	0.52	3.13
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5	35.97	14.84	1.51	1.51	0.50
Adipocyte - omental, donor1.CNhs11054.11473-119C6	35.94	24.53	2.40	1.41	0.00
blood, adult, pool1.CNhs11761.10053-101G8	35.92	45.50	9.58	0.00	2.39
brain, adult, donor1.CNhs11796.10084-102B3	35.87	29.08	3.88	2.91	0.97
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9	35.86	16.30	1.37	1.72	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5	35.62	24.40	0.49	1.95	0.98
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7	35.54	85.72	16.73	0.00	0.00
Mesothelial Cells, donor3.CNhs12012.11402-118D7	35.49	13.50	1.60	1.40	0.60
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3	35.49	61.37	2.62	1.00	1.00
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8	35.46	34.56	2.15	0.36	0.36
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2	35.45	18.41	1.11	1.87	0.51
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2	35.44	25.72	2.29	2.86	1.71
gall bladder, adult.CNhs12848.10198-103E9	35.43	27.11	0.85	0.85	0.64
testis, adult, pool1.CNhs10632.10026-101D8	35.39	31.15	4.93	1.44	0.53
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7	35.31	18.69	1.56	2.08	0.52
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9	35.26	26.94	1.42	1.32	0.66
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8	35.21	17.08	1.39	2.67	0.58
umbilical cord, fetal, donor1.CNhs11765.10057-101H3	35.20	16.42	2.35	2.35	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2	35.09	25.06	2.51	2.51	0.00
Mast cell, donor1.CNhs12566.11563-120D6	35.04	15.32	0.35	1.58	0.70
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2	34.98	36.26	3.53	0.96	2.25
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3	34.96	64.10	2.59	1.29	0.00
Eosinophils, donor3.CNhs12549.12246-129H5	34.90	31.02	3.88	0.00	0.00
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9	34.87	43.23	1.73	0.58	1.15
CD8+ T Cells, donor3.CNhs11999.11383-118B6	34.76	57.21	11.59	0.29	2.46
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1	34.75	50.20	1.93	1.93	1.93
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8	34.70	10.50	0.29	1.46	0.29
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1	34.59	31.83	2.45	0.92	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6	34.59	16.76	0.75	0.97	0.97
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8	34.44	22.96	2.09	4.70	1.57
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9	34.23	13.84	0.55	1.46	0.18
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1	34.10	27.58	1.95	0.43	0.65
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8	34.09	55.43	2.55	0.96	0.32
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6	34.07	19.66	0.44	0.76	0.55
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7	34.06	25.31	1.95	0.00	1.46
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9	34.00	11.59	0.77	1.80	1.55
liver, adult, pool1.CNhs10624.10018-101C9	34.00	41.47	1.61	0.88	0.73
vagina, adult.CNhs12854.10204-103F6	33.95	8.65	0.00	3.33	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3	33.88	29.46	2.95	0.00	0.74
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6	33.85	15.42	0.55	1.09	0.41
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4	33.83	13.71	0.62	2.94	0.18
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3	33.78	19.33	1.39	1.04	1.04
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4	33.74	46.72	5.19	1.11	0.00
Sertoli Cells, donor1.CNhs10851.11255-116F4	33.74	27.32	1.61	0.00	0.00
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6	33.68	41.67	1.08	1.51	0.00
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7	33.64	26.68	1.45	1.16	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1	33.57	66.73	3.64	0.54	1.15
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3	33.52	15.90	2.15	1.29	0.86
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9	33.39	77.28	3.82	0.00	0.00
spinal cord, fetal, donor1.CNhs11764.10056-101H2	33.39	27.90	0.85	1.69	0.00
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2	33.34	30.01	1.11	1.11	2.22
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4	33.33	43.66	4.67	1.11	0.49
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5	33.29	31.11	1.64	0.55	2.46
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5	33.25	53.55	0.66	0.33	0.49
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6	33.23	21.87	0.51	1.19	0.17
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8	33.12	169.50	19.48	0.00	1.95
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3	33.12	39.81	1.20	0.69	0.69
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1	33.09	39.32	1.93	0.23	0.34
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3	33.09	5.34	0.00	1.07	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7	33.06	13.22	0.90	1.95	0.45
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6	33.05	18.92	0.76	1.77	0.50
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7	33.04	29.85	1.59	1.59	0.58
testis, adult, pool2.CNhs12998.10096-102C6	32.96	24.65	5.09	1.88	0.80
Eosinophils, donor2.CNhs12548.12245-129H4	32.95	31.63	3.95	0.00	1.32
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9	32.81	60.93	3.75	0.94	1.87
skeletal muscle, adult, pool1.CNhs10629.10023-101D5	32.75	46.40	2.46	1.33	0.31
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6	32.64	10.99	1.00	1.33	0.67
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1	32.59	9.82	1.44	1.44	0.24
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6	32.45	25.54	1.38	0.69	0.69
Myoblast, donor1.CNhs10870.11241-116D8	32.43	18.82	1.01	2.17	0.87
parotid gland, adult.CNhs12849.10199-103F1	32.35	37.83	0.00	0.55	2.74
heart - tricuspid valve, adult.CNhs12857.10207-103F9	32.30	7.18	0.00	2.87	1.44
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4	32.22	17.69	1.90	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5	32.20	11.13	1.86	0.66	0.40
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7	32.13	4.35	0.33	1.00	0.00
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3	32.00	32.87	1.26	1.64	0.29
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8	32.00	11.08	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7	31.85	13.99	1.20	0.83	0.18
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2	31.80	30.42	7.04	0.64	1.07
amniotic membrane cells, donor2.CNhs12503.12236-129G4	31.78	26.13	0.59	0.59	0.00
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2	31.68	82.72	1.76	0.00	0.00
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5	31.64	24.94	0.56	0.74	0.00
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8	31.59	7.72	0.70	2.81	1.17
mature adipocyte, donor2.CNhs12559.12232-129F9	31.59	39.36	2.26	0.50	0.25
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1	31.51	16.05	0.47	1.52	0.47
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2	31.48	30.27	1.21	0.61	0.61
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4	31.44	10.80	0.19	1.33	0.38
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1	31.37	12.76	1.38	1.72	0.00
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6	31.30	16.50	0.46	1.23	0.15
Neural stem cells, donor2.CNhs11384.11352-117H2	31.23	33.84	3.90	1.30	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8	31.17	23.27	0.88	2.19	0.88
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3	31.17	41.91	0.89	0.38	1.41
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9	31.10	17.73	0.93	2.18	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9	31.10	17.00	0.41	2.49	0.41
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5	30.98	12.18	0.18	0.26	0.18
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5	30.95	34.85	4.14	0.49	1.95
Natural Killer Cells, donor1.CNhs10859.11230-116C6	30.93	38.62	9.46	0.39	1.97
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2	30.89	26.32	1.91	1.53	0.38
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3	30.76	19.37	0.00	0.57	0.00
eye, fetal, donor1.CNhs11762.10054-101G9	30.73	24.41	1.36	1.13	0.68
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2	30.66	45.99	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2	30.59	13.76	0.00	0.00	1.53
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3	30.57	9.04	0.80	1.33	1.33
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4	30.53	27.47	3.49	2.62	0.00
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5	30.39	69.46	1.56	0.89	0.45
spleen, adult, pool1.CNhs10631.10025-101D7	30.36	15.70	0.85	0.75	0.38
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9	30.35	42.31	0.67	1.52	1.52
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3	30.31	20.32	0.46	0.92	0.11
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3	30.26	18.61	1.39	1.52	0.51
liposarcoma cell line:SW 872.CNhs11851.10726-110A6	30.25	49.52	1.13	1.47	0.91
glioblastoma cell line:T98G.CNhs11272.10485-107A8	30.19	31.52	0.51	0.71	0.20
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5	30.12	15.87	1.30	1.94	0.00
hepatoma cell line:Li-7.CNhs11271.10484-107A7	30.12	23.82	1.38	0.59	0.49
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9	30.11	47.10	2.32	0.44	1.54
meningioma cell line:HKBMM.CNhs11945.10691-109F7	30.11	25.64	0.47	0.71	0.94
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2	30.07	26.36	0.51	0.84	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6	30.00	33.40	1.80	1.00	0.40
Neutrophils, donor2.CNhs11959.11314-117C9	29.92	5.98	2.99	0.00	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1	29.76	148.52	9.47	0.60	5.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7	29.75	19.18	1.04	2.18	0.52
diencephalon, adult.CNhs12610.10193-103E4	29.75	39.36	1.87	0.94	0.23
occipital lobe, fetal, donor1.CNhs11784.10073-102A1	29.74	24.45	1.26	3.78	0.00
Meningeal Cells, donor3.CNhs12731.11654-122E7	29.70	9.53	0.37	1.32	0.22
aorta, adult, pool1.CNhs11760.10052-101G7	29.69	21.12	1.20	1.39	0.00
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5	29.65	26.89	2.07	0.00	1.72
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8	29.65	35.95	2.90	0.85	0.34
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9	29.64	32.73	2.78	1.54	2.47
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6	29.56	46.80	2.46	0.82	0.82
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6	29.53	13.88	0.25	0.76	0.00
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6	29.51	35.13	2.34	1.41	0.47
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3	29.45	37.92	0.81	1.82	2.22
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4	29.43	23.73	2.85	0.00	2.53
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3	29.41	15.74	0.41	0.83	0.41
CD14+ Monocytes, donor1.CNhs10852.11224-116B9	29.36	24.93	1.11	0.55	0.55
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1	29.36	32.20	3.08	0.24	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5	29.35	163.34	14.20	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2	29.21	65.39	6.67	0.89	0.89
spleen, fetal, pool1.CNhs10651.10044-101F8	29.20	10.83	0.77	1.03	0.32
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9	29.13	14.34	0.89	1.03	0.15
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3	29.12	26.79	0.00	0.00	2.33
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7	29.00	17.38	1.06	1.76	0.59
gastric cancer cell line:AZ521.CNhs11286.10549-107H9	28.98	30.81	3.78	0.57	0.11
melanoma cell line:COLO 679.CNhs11281.10514-107E1	28.96	36.24	1.97	1.67	0.61
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1	28.92	18.78	0.00	0.51	0.51
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5	28.91	36.98	0.00	2.69	0.00
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6	28.89	6.43	0.50	1.39	1.26
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7	28.85	8.09	0.55	0.98	0.00
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3	28.84	12.03	0.99	0.33	1.81
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8	28.83	16.44	0.43	0.21	0.00
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8	28.80	19.75	0.41	0.82	0.00
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5	28.79	35.37	1.13	1.81	0.68
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8	28.74	40.71	0.00	0.00	0.00
Reticulocytes, biol_rep1.CNhs13552.11931-125I5	28.72	19.08	1.32	0.66	0.00
Preadipocyte - omental, donor3.CNhs12013.11403-118D8	28.63	17.69	0.97	1.13	0.16
optic nerve, donor1.CNhs13449.10277-104E7	28.55	39.98	9.99	0.00	0.00
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2	28.50	13.39	0.25	1.31	0.41
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3	28.47	31.05	0.56	0.67	1.57
Neutrophils, donor1.CNhs10862.11233-116C9	28.46	8.99	3.00	0.00	0.00
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7	28.41	12.25	0.35	0.78	0.35
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6	28.40	22.59	1.94	0.00	0.00
colon, adult, pool1.CNhs10619.10014-101C5	28.39	41.66	2.74	0.71	0.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1	28.35	12.58	0.80	1.43	0.32
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8	28.16	66.10	4.60	2.87	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1	28.11	42.27	1.09	1.09	1.31
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3	28.08	16.70	1.42	1.07	0.36
occipital pole, adult, pool1.CNhs10643.10036-101E9	28.08	23.38	1.31	1.24	0.14
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8	28.04	42.12	2.37	0.71	2.01
Basophils, donor2.CNhs12563.12242-129H1	28.02	34.93	3.07	0.00	1.54
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1	27.96	9.21	0.16	0.48	0.32
epididymis, adult.CNhs12847.10197-103E8	27.96	50.15	2.97	1.05	0.17
salivary gland, adult, pool1.CNhs11677.10093-102C3	27.96	32.27	0.86	0.86	0.43
tenocyte, donor1.CNhs12639.11763-123H8	27.90	11.90	1.86	0.74	0.00
lung, adult, pool1.CNhs10625.10019-101D1	27.87	17.30	0.75	0.64	0.00
cerebral meninges, adult.CNhs12840.10188-103D8	27.86	41.46	2.63	1.97	0.66
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8	27.84	86.21	5.37	0.00	0.67
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9	27.74	65.29	5.97	0.43	0.85
Keratocytes, donor1.CNhs11337.11527-119I6	27.69	48.22	1.63	0.33	0.00
migratory langerhans cells, donor1.CNhs13535.11901-125F2	27.67	9.16	0.58	1.56	0.19
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4	27.63	47.96	2.43	0.90	0.77
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6	27.56	28.70	0.28	1.42	1.70
submaxillary gland, adult.CNhs12852.10202-103F4	27.52	34.40	0.92	2.29	0.00
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5	27.48	43.73	2.50	0.00	2.50
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4	27.38	12.25	0.72	1.80	0.72
parietal lobe, fetal, donor1.CNhs11782.10072-101I9	27.35	17.50	1.64	3.28	0.00
uterus, fetal, donor1.CNhs11763.10055-101H1	27.26	18.72	1.22	0.41	0.00
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1	27.25	29.91	1.33	0.00	0.00
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4	27.24	11.67	0.65	0.00	0.00
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5	27.16	26.70	1.18	0.79	0.20
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7	27.09	30.39	2.07	0.21	0.83
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7	27.07	14.43	0.79	0.40	1.78
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9	27.03	30.53	1.27	2.54	0.64
vein, adult.CNhs12844.10191-103E2	26.97	23.15	1.61	1.61	0.20
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1	26.79	15.51	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9	26.70	12.08	0.64	0.42	0.42
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1	26.68	18.20	0.71	2.12	0.53
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8	26.67	30.08	1.40	1.20	1.40
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1	26.67	55.14	1.61	0.18	0.72
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1	26.67	16.72	0.80	1.59	0.00
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4	26.57	5.12	0.38	1.14	0.19
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3	26.50	10.09	1.26	1.26	2.52
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5	26.49	40.23	1.57	0.98	1.18
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9	26.36	12.01	0.17	2.34	0.50
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1	26.31	37.45	8.35	0.00	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4	26.29	43.28	2.97	1.48	2.29
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9	26.26	15.91	0.80	0.99	0.40
Melanocyte - dark, donor3.CNhs12570.11663-122F7	26.22	12.45	1.27	2.03	0.63
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2	26.21	25.32	1.18	0.79	0.39
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2	26.10	35.35	2.14	2.14	0.47
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6	26.05	35.08	2.11	0.45	0.30
Cardiac Myocyte, donor3.CNhs12571.11686-122I3	25.96	19.44	1.53	0.77	0.26
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1	25.93	14.26	0.72	0.72	0.58
migratory langerhans cells, donor2.CNhs13536.11902-125F3	25.91	14.22	0.66	0.80	0.40
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2	25.89	23.23	0.76	0.00	0.38
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6	25.85	30.26	0.77	2.87	0.57
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9	25.79	51.30	1.45	1.16	0.00
cervix, adult, pool1.CNhs10618.10013-101C4	25.78	20.01	0.54	0.77	0.08
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8	25.73	20.22	1.19	1.47	0.74
Neural stem cells, donor1.CNhs11063.11275-116H6	25.66	35.83	2.54	0.51	0.00
stomach, fetal, donor1.CNhs11771.10062-101H8	25.56	46.74	2.19	0.73	0.73
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8	25.55	15.74	0.43	1.62	0.11
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4	25.55	28.30	0.69	1.03	0.51
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6	25.54	26.67	0.57	0.00	0.00
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3	25.52	17.12	1.24	1.24	0.00
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3	25.51	67.30	5.92	0.74	0.37
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6	25.51	7.20	0.30	1.20	0.60
esophagus, adult, pool1.CNhs10620.10015-101C6	25.51	22.70	0.48	1.36	0.19
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4	25.50	9.84	0.67	0.67	0.22
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5	25.42	15.46	0.69	1.37	1.37
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8	25.39	18.52	1.59	0.53	0.00
skin, fetal, donor1.CNhs11774.10065-101I2	25.26	16.03	0.49	1.46	0.97
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2	24.99	17.17	1.09	0.54	0.33
tongue, fetal, donor1.CNhs11768.10059-101H5	24.98	23.27	2.74	1.37	0.68
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4	24.91	15.72	1.02	0.82	0.61
prostate, adult, pool1.CNhs10628.10022-101D4	24.88	18.13	1.10	1.10	0.24
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5	24.84	13.50	1.62	1.62	0.54
trachea, adult, pool1.CNhs10635.10029-101E2	24.82	17.21	1.29	0.79	0.57
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5	24.77	11.76	0.50	1.38	0.88
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6	24.76	12.08	0.85	1.10	0.73
throat, fetal, donor1.CNhs11770.10061-101H7	24.76	24.28	0.48	1.67	0.48
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5	24.58	26.23	0.55	0.55	1.10
cerebellum, adult, pool1.CNhs11795.10083-102B2	24.53	35.76	0.59	0.59	0.00
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9	24.50	42.40	1.57	0.47	1.57
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1	24.49	16.68	0.12	0.83	0.24
CD8+ T Cells, donor1.CNhs10854.11226-116C2	24.39	49.60	10.69	0.20	3.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3	24.38	13.99	0.87	1.59	0.29
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3	24.27	13.21	0.31	0.92	0.31
small intestine, fetal, donor1.CNhs11773.10064-101I1	24.26	29.51	1.31	1.53	0.22
pancreas, adult, donor1.CNhs11756.10049-101G4	24.23	30.48	1.56	0.78	0.78
tongue, adult.CNhs12853.10203-103F5	24.17	34.40	0.87	0.65	0.22
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4	24.09	46.23	0.65	0.65	0.00
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9	24.09	14.73	0.46	1.38	0.31
Sebocyte, donor2.CNhs11951.11301-117B5	24.05	31.85	0.00	0.65	0.00
prostate cancer cell line:PC-3.CNhs11243.10439-106E7	23.91	18.91	0.67	0.78	1.00
thyroid, fetal, donor1.CNhs11769.10060-101H6	23.85	31.93	0.81	0.20	0.20
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6	23.83	18.61	0.82	1.14	0.16
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4	23.80	55.53	2.64	0.66	0.00
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3	23.80	22.03	0.77	1.23	0.31
kidney, fetal, pool1.CNhs10652.10045-101F9	23.71	25.70	1.42	0.84	0.10
seminal vesicle, adult.CNhs12851.10201-103F3	23.71	42.34	0.42	0.85	0.00
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4	23.67	19.69	0.23	1.25	0.23
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1	23.62	40.01	0.96	0.96	1.93
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5	23.61	53.53	2.36	0.26	0.35
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3	23.59	27.31	3.28	0.66	0.22
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8	23.56	19.84	0.72	1.14	0.72
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2	23.37	21.50	0.47	0.93	0.70
colon, fetal, donor1.CNhs11780.10070-101I7	23.22	26.27	1.22	0.61	0.00
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3	23.19	11.54	0.72	1.44	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6	23.14	10.98	0.39	1.37	0.20
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1	23.10	7.65	0.33	0.83	0.17
CD4+ T Cells, donor1.CNhs10853.11225-116C1	23.02	40.33	7.08	0.20	0.39
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5	23.01	11.96	1.35	0.90	0.23
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4	23.00	17.25	0.78	0.29	0.10
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5	22.82	61.66	2.00	0.40	0.00
astrocytoma cell line:TM-31.CNhs10742.10425-106D2	22.81	21.07	1.84	0.20	0.00
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2	22.78	29.31	1.54	0.26	0.26
CD19+ B Cells, donor1.CNhs12343.11544-120B5	22.77	105.30	7.40	0.57	1.71
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3	22.77	10.79	0.30	0.15	0.30
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4	22.69	17.63	0.95	1.16	0.21
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7	22.67	18.37	0.64	1.50	0.21
smooth muscle, adult, pool1.CNhs11755.10048-101G3	22.55	12.99	0.25	0.25	0.00
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1	22.53	29.14	2.75	0.72	0.13
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4	22.47	78.12	6.42	0.80	0.00
diaphragm, fetal, donor1.CNhs11779.10069-101I6	22.47	23.27	0.00	0.80	1.61
olfactory region, adult.CNhs12611.10195-103E6	22.45	22.28	1.13	0.65	0.48
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7	22.39	16.44	0.71	0.48	0.24
myeloma cell line:PCM6.CNhs11258.10474-106I6	22.39	119.00	2.93	0.17	0.69
amygdala, adult, donor10252.CNhs12311.10151-102I7	22.37	10.27	0.56	0.28	0.56
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7	22.37	42.21	3.31	1.02	0.51
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7	22.34	23.81	1.07	0.74	0.74
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1	22.33	15.93	0.77	1.02	0.34
glioblastoma cell line:A172.CNhs11185.10444-106F3	22.28	34.62	0.84	0.52	0.10
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2	22.27	15.01	0.40	0.91	0.20
Mallassez-derived cells, donor3.CNhs13551.11930-125I4	22.26	18.29	1.28	0.99	0.14
adipose tissue, adult, pool1.CNhs10615.10010-101C1	22.12	15.82	0.15	0.73	0.29
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5	22.06	19.16	0.19	0.77	1.35
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1	22.05	9.04	0.72	0.72	0.72
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3	22.01	10.65	0.36	1.07	0.36
pineal gland - adult, donor10196.CNhs13804.10179-103C8	21.96	18.21	2.14	1.07	0.54
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4	21.94	25.32	0.94	0.66	0.38
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6	21.84	34.59	3.09	1.35	0.39
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8	21.75	20.56	0.85	0.34	0.85
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5	21.68	9.73	0.48	0.80	0.32
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7	21.67	25.73	5.42	4.06	2.71
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3	21.64	17.78	0.26	1.03	0.52
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2	21.51	26.39	1.72	0.29	0.57
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1	21.47	22.70	0.74	0.86	0.25
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3	21.41	29.06	2.55	1.53	0.51
putamen, adult, donor10196.CNhs12324.10176-103C5	21.37	23.41	0.47	0.31	0.16
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3	21.35	29.82	1.88	1.57	1.88
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2	21.35	40.41	0.57	0.28	0.00
insula, adult, pool1.CNhs10646.10039-101F3	21.32	14.46	0.73	0.91	0.30
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5	21.31	13.29	0.00	0.50	0.00
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7	21.30	50.79	0.55	0.55	0.55
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9	21.23	10.33	1.43	1.15	0.29
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3	21.20	30.99	1.36	1.09	0.27
CD19+ B Cells, donor2.CNhs12352.11624-122B4	21.14	93.96	9.98	0.59	1.76
small intestine, adult, pool1.CNhs10630.10024-101D6	21.07	34.88	1.54	0.46	0.46
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8	21.02	28.52	1.29	0.64	0.43
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6	20.98	30.66	1.84	0.92	0.23
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5	20.92	25.35	1.24	0.82	0.62
uterus, adult, pool1.CNhs11676.10100-102D1	20.90	17.11	0.73	0.98	0.24
ovary, adult, pool1.CNhs10626.10020-101D2	20.76	24.97	0.68	0.98	0.08
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4	20.71	58.01	2.26	0.29	0.39
hippocampus, adult, donor10252.CNhs12312.10153-102I9	20.70	13.08	0.68	1.09	0.95
heart - mitral valve, adult.CNhs12855.10205-103F7	20.67	11.73	0.84	1.40	0.28
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1	20.63	14.05	0.29	0.88	0.39
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3	20.62	19.40	1.22	0.49	0.00
Osteoblast, donor2.CNhs11385.11354-117H4	20.59	9.30	0.00	1.99	0.00
mature adipocyte, donor3.CNhs12560.12233-129G1	20.53	48.71	1.53	0.31	0.31
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5	20.52	20.69	0.99	0.74	0.66
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3	20.44	38.76	1.41	0.00	0.70
penis, adult.CNhs12850.10200-103F2	20.34	21.34	0.50	0.99	0.50
Mallassez-derived cells, donor2.CNhs13550.11929-125I3	20.33	13.94	0.67	1.51	0.17
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3	20.26	12.05	0.93	0.93	0.93
dura mater, adult, donor1.CNhs10648.10041-101F5	20.22	17.57	0.88	0.82	0.25
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4	20.19	35.07	1.20	0.68	0.34
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7	20.16	16.73	1.00	1.14	0.14
mature adipocyte, donor1.CNhs12558.12231-129F8	20.13	53.86	3.26	0.00	0.54
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1	20.06	10.50	0.31	1.57	0.16
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4	20.02	31.44	3.18	0.37	1.50
retina, adult, pool1.CNhs10636.10030-101E3	20.01	28.02	0.64	0.43	0.21
bladder, adult, pool1.CNhs10616.10011-101C2	19.93	14.30	0.49	0.79	0.10
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7	19.79	17.87	0.64	0.00	0.00
middle temporal gyrus, donor10252.CNhs12316.10156-103A3	19.77	14.52	0.14	0.83	0.55
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2	19.66	21.59	0.96	0.24	0.60
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9	19.59	21.57	1.08	0.45	1.44
thyroid, adult, pool1.CNhs10634.10028-101E1	19.54	36.22	1.15	0.57	0.32
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1	19.45	47.33	2.11	1.87	0.47
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3	19.45	18.93	0.35	0.87	0.87
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1	19.45	27.87	1.84	0.79	1.84
thymus, fetal, pool1.CNhs10650.10043-101F7	19.43	14.46	0.50	0.62	0.12
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8	19.38	16.88	0.61	0.81	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6	19.24	49.25	4.23	0.38	0.38
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9	19.19	7.71	0.72	0.18	0.18
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9	19.12	7.76	0.28	1.66	0.28
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2	19.09	33.71	1.03	0.17	0.17
melanoma cell line:G-361.CNhs11254.10465-106H6	18.84	19.41	0.29	0.57	0.00
parietal lobe, adult, donor10252.CNhs12317.10157-103A4	18.81	14.47	0.62	0.83	0.21
kidney, adult, pool1.CNhs10622.10017-101C8	18.76	37.12	1.50	0.79	0.32
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2	18.64	14.20	1.15	1.00	0.14
amniotic membrane cells, donor1.CNhs12502.12235-129G3	18.62	15.76	2.86	0.72	2.63
throat, adult.CNhs12858.10209-103G2	18.55	27.72	1.92	1.07	0.43
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6	18.46	9.29	0.43	0.75	0.43
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2	18.45	38.36	0.73	0.49	2.43
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6	18.39	26.41	1.17	0.39	0.20
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3	18.29	34.65	1.92	0.96	0.00
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6	18.27	18.55	1.64	1.91	0.82
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1	18.25	24.63	1.28	1.09	0.91
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3	18.15	47.30	2.87	0.48	0.00
placenta, adult, pool1.CNhs10627.10021-101D3	18.01	17.03	1.33	0.71	0.27
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1	17.92	14.77	1.09	0.45	0.19
amygdala - adult, donor10196.CNhs13793.10167-103B5	17.89	17.89	2.98	0.00	0.00
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7	17.72	23.50	0.39	0.96	0.58
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5	17.64	15.42	1.48	0.63	0.74
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2	17.42	16.97	0.55	0.55	0.55
heart, fetal, pool1.CNhs10653.10046-101G1	17.40	12.36	0.40	0.74	0.13
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6	17.37	16.57	1.34	0.27	0.53
ductus deferens, adult.CNhs12846.10196-103E7	17.36	34.33	1.97	0.79	0.39
rectum, fetal, donor1.CNhs11777.10067-101I4	17.35	10.04	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6	17.31	13.41	0.85	0.73	0.12
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7	17.29	8.39	0.34	0.17	0.34
occipital cortex, adult, donor10252.CNhs12320.10163-103B1	17.24	10.06	0.64	0.32	0.16
appendix, adult.CNhs12842.10189-103D9	17.13	25.69	1.66	0.28	0.55
mature adipocyte, donor4.CNhs12562.12234-129G2	17.05	54.75	1.64	1.31	0.00
Neutrophils, donor3.CNhs11905.11390-118C4	16.99	8.29	2.49	0.83	0.00
brain, adult, pool1.CNhs10617.10012-101C3	16.98	29.04	1.11	0.83	0.28
frontal lobe, adult, pool1.CNhs10647.10040-101F4	16.97	12.85	0.76	0.89	0.19
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3	16.93	18.12	0.66	0.13	0.53
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9	16.73	40.62	1.19	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5	16.72	13.94	0.37	0.19	0.37
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9	16.72	29.10	0.69	0.46	0.46
tonsil, adult, pool1.CNhs10654.10047-101G2	16.57	18.59	0.67	0.47	0.00
CD19+ B Cells, donor3.CNhs12354.11705-123B4	16.44	94.04	8.41	0.00	0.76
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8	16.39	16.49	1.11	0.20	0.00
thalamus, adult, donor10252.CNhs12314.10154-103A1	16.34	15.83	0.93	0.21	0.62
parietal lobe, adult, pool1.CNhs10641.10034-101E7	16.30	15.85	0.89	1.27	0.19
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6	16.27	14.65	0.63	0.50	0.38
immature langerhans cells, donor2.CNhs13480.11905-125F6	16.25	51.07	4.64	0.00	1.55
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2	16.18	22.38	0.20	0.60	0.20
glioma cell line:GI-1.CNhs10731.10413-106B8	16.18	11.56	0.58	0.58	0.87
Sebocyte, donor1.CNhs10847.11220-116B5	16.08	11.49	1.15	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2	16.04	12.71	0.20	0.39	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6	16.02	7.97	0.27	0.64	0.37
prostate cancer cell line:DU145.CNhs11260.10490-107B4	15.96	30.85	1.77	0.95	0.71
salivary acinar cells, donor3.CNhs12812.11773-123I9	15.90	47.70	0.69	0.69	1.38
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5	15.88	32.81	2.60	0.87	0.58
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3	15.74	8.50	0.63	0.00	0.00
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9	15.71	22.08	0.72	0.54	0.18
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4	15.71	45.52	3.93	0.46	1.04
immature langerhans cells, donor1.CNhs13537.11904-125F5	15.52	34.87	3.15	0.00	1.80
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3	15.47	23.82	2.20	0.55	0.55
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7	15.32	26.16	0.47	0.94	0.47
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1	15.28	29.32	0.75	0.12	0.12
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1	15.22	12.87	0.42	0.55	0.28
salivary acinar cells, donor2.CNhs12811.11772-123I8	15.19	25.95	1.37	0.51	0.85
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8	15.13	42.31	2.13	0.24	0.47
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4	15.10	71.41	2.72	0.45	1.66
lung, fetal, donor1.CNhs11680.10068-101I5	15.09	10.22	0.16	0.16	0.00
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6	15.06	26.57	0.89	0.89	0.00
corpus callosum, adult, pool1.CNhs10649.10042-101F6	15.03	13.48	0.54	0.54	0.07
pituitary gland, adult, donor10252.CNhs12229.10162-103A9	15.03	10.24	0.68	0.68	0.46
thalamus - adult, donor10196.CNhs13794.10168-103B6	14.93	27.36	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7	14.84	34.53	2.22	0.55	0.69
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9	14.78	6.09	0.00	1.04	0.00
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5	14.62	14.40	0.66	0.88	0.55
heart - pulmonic valve, adult.CNhs12856.10206-103F8	14.44	16.50	0.23	0.92	0.69
salivary acinar cells, donor1.CNhs12810.11771-123I7	14.30	24.24	0.62	0.41	0.21
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9	14.28	16.59	0.58	0.77	0.19
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8	14.18	31.01	3.54	1.77	0.00
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4	14.15	5.88	0.64	0.48	0.16
pineal gland, adult, donor10252.CNhs12228.10160-103A7	14.12	3.70	0.00	1.01	0.34
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3	14.09	27.18	1.48	0.49	0.25
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6	14.07	18.61	0.22	0.65	0.22
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1	14.01	25.79	0.84	0.28	0.28
Hepatocyte, donor1.CNhs12340.11523-119I2	13.94	76.05	1.27	1.27	1.27
substantia nigra, adult, donor10252.CNhs12318.10158-103A5	13.90	15.48	0.57	0.43	0.00
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2	13.84	41.32	2.88	0.38	0.19
amniotic membrane cells, donor3.CNhs12379.12237-129G5	13.82	17.20	1.84	0.61	1.54
globus pallidus - adult, donor10196.CNhs13801.10175-103C4	13.81	27.02	0.60	0.60	0.00
cervical cancer cell line:ME-180.CNhs11289.10553-107I4	13.66	36.11	1.53	0.14	0.84
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2	13.57	28.96	1.55	0.52	0.13
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5	13.46	32.06	0.96	0.32	0.64
spinal cord, adult, donor10252.CNhs12227.10159-103A6	13.37	13.66	1.19	0.30	0.00
pituitary gland - adult, donor10196.CNhs13805.10180-103C9	13.35	21.24	2.43	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5	13.28	4.04	0.17	0.99	0.08
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8	13.25	22.16	1.16	0.39	1.01
medulla oblongata, adult, pool1.CNhs10645.10038-101F2	13.23	20.43	0.75	0.50	0.19
spinal cord - adult, donor10196.CNhs13807.10181-103D1	13.15	24.93	0.98	0.59	0.59
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2	12.91	20.19	0.99	0.00	0.99
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6	12.74	17.89	0.49	0.49	0.49
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9	12.71	31.58	2.39	0.37	0.18
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4	12.70	21.16	0.73	0.41	0.16
Urothelial cells, donor0.CNhs10843.11216-116B1	12.63	10.34	0.69	0.92	0.23
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9	12.32	8.95	0.34	1.18	0.34
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1	12.27	10.62	1.06	0.59	0.12
cerebellum, adult, donor10252.CNhs12323.10166-103B4	12.16	8.96	0.22	0.22	0.22
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2	11.84	38.84	2.43	0.30	0.20
parietal lobe - adult, donor10196.CNhs13797.10171-103B9	11.72	26.56	3.12	2.34	0.00
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1	11.63	26.32	0.68	0.34	1.36
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4	11.61	21.32	1.27	0.42	1.27
globus pallidus, adult, donor10252.CNhs12319.10161-103A8	11.50	12.87	0.82	0.55	0.27
chorionic membrane cells, donor1.CNhs12504.12238-129G6	11.48	22.33	2.55	0.32	0.96
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3	11.47	34.40	2.29	0.00	0.00
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8	11.38	27.05	0.94	0.10	0.10
occipital cortex - adult, donor10196.CNhs13798.10172-103C1	11.34	11.34	1.42	0.00	0.00
Mast cell - stimulated, donor1.CNhs11073.11487-119E2	11.33	10.84	0.00	0.49	0.49
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8	11.32	32.47	2.35	0.32	0.32
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8	11.32	33.78	1.15	0.58	1.15
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4	11.25	6.61	0.54	0.18	0.18
Keratinocyte - oral, donor1.CNhs10879.11251-116E9	11.20	16.39	1.67	0.37	0.00
nasal epithelial cells, donor2.CNhs12574.12227-129F4	11.20	24.26	3.11	0.00	0.00
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3	11.19	50.22	2.52	0.70	0.56
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2	10.99	6.92	0.41	0.41	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6	10.96	19.92	0.71	0.43	0.43
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3	10.92	16.34	0.66	0.33	0.16
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3	10.89	27.23	1.85	0.44	0.44
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4	10.78	19.13	0.08	0.39	0.24
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8	10.71	15.50	0.96	0.44	0.52
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2	10.55	18.34	0.23	0.46	0.15
hippocampus - adult, donor10196.CNhs13795.10169-103B7	10.34	22.27	3.18	1.59	0.00
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7	10.33	24.56	1.19	0.34	0.08
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7	10.25	13.04	0.11	0.22	1.00
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1	10.09	13.59	0.20	0.90	0.30
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7	10.03	28.63	1.71	0.00	0.24
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5	9.75	31.73	2.15	0.83	0.17
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1	9.74	52.86	1.46	0.37	0.37
chorionic membrane cells, donor3.CNhs12380.12240-129G8	9.59	15.46	0.53	0.00	1.07
pons, adult, pool1.CNhs10640.10033-101E6	9.58	24.47	0.88	0.41	0.20
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1	9.51	14.16	1.69	0.00	0.42
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6	9.36	17.91	0.29	0.22	0.44
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9	9.30	24.99	1.74	0.00	0.00
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3	9.22	20.86	0.92	0.58	0.69
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1	8.74	11.94	0.48	0.16	0.08
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4	8.72	16.97	0.23	0.12	0.23
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7	8.52	4.18	0.55	0.32	0.08
retinoblastoma cell line:Y79.CNhs11267.10475-106I7	8.37	18.80	1.42	0.32	0.47
cerebellum - adult, donor10196.CNhs13799.10173-103C2	7.63	4.58	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4	7.54	29.70	1.41	0.00	0.71
b cell line:RPMI1788.CNhs10744.10427-106D4	7.26	17.23	0.49	0.25	0.25
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4	6.27	26.24	1.34	0.27	0.09
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2	6.23	27.28	1.19	0.00	0.30
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3	5.98	14.11	1.27	0.10	0.20
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8	4.55	26.02	0.43	0.28	0.43
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6	4.47	12.38	1.53	0.38	0.00
Adipocyte - breast, donor1.CNhs11051.11376-118A8	0.00	0.00	0.00	0.00	0.00

Showing 1 to 889 of 889 entries

0

50

100

150

200

250

300

350

400

Click each plot point to find sample in table

ENCODE TF ChIP-seq peak enrichment analysis Analyst: Erik Arner Summary: For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. link to source dataset. data

No analysis results for this cluster

DetailsSummary:It includes sequences from the international sequence collaboration, Swiss-Prot, and RefSeq. The RefSeq subset of this file is also available as gene2refseq. links to source dataset. human mouse

GeneID:	51282
LocusTag:	-
chromosome:	20
map location:	20q11.1-q11.23
type of gene:	protein-coding
Symbol from nomenclature authority:	SCAND1
Full name from nomenclature authority:	SCAN domain containing 1
Nomenclature status:	O
Other designations:	SCAN domain-containing 1, SCAN domain-containing protein 1, SCAN-related protein RAZ1, SCAN domain-containing 1;;SCAN domain-containing protein 1;;SCAN-related protein RAZ1
Modification date:	08.01.2012

Personal tools

EntrezGene:51282 - resource_browser

Search

Human

Mouse

Rat

Dog

Chicken

Macaque

Cross species

Other

Tools

EntrezGene:51282

From FANTOM5_SSTAR

	FAQ
	Mozilla Cavendish skin modified by DaSch for the Web Community Wiki GitHub project page – Report a bug – Skin version: 2.6.0